ILSI-Biomed Israel 2010 Week: Practical Seminars Will Be Instructed by 32 Experts from Worldwide Leading Life–Scienc

Subjects Covered by the Seminars Include: Cardiology, the Development of New Vaccines, Stem Cells, Metabolic Disease, E-volving Promises of Efficiency and Empowerment in Healthcare, Personalized Medicine and Oncology

TEL AVIV, Israel--(BUSINESS WIRE)-- The ILSI–Biomed Israel 2010 Week, the key annual life–sciences event in Israel, that will be launched on June the 13th, 2010, will hold this year professional seminars dealing with some of the hottest issues of the medical fields. Thirty two senior members of the world industry will come to Israel for the event and throughout the conference days will discuss the various subjects like Cardiology, the Development of New vaccines, the use of Stem Cells, Metabolic Disease, Personalized Medicine, Regulation, E-volving promises of efficiency and empowerment in healthcare and Oncology.

The first day of the event (June 13th) will be dedicated to a seminar Presented by Cleveland Clinic, Global Cardiovascular Innovation Center and the Israel Life Sciences Industries, under the title: "Medical Innovation: From Idea to Bench to Bedside - A Biomedical Innovation Summit."

For doctors, researchers, and for the Biomed professionals in Israel, this will be an opportunity to meet some of the world leading names in the area, e.g. Scott Gallichan, Sanofi Pasteur; Dr. Bryant M. Moore, Medtronic Inc.; Dr. Hugues Bogarts, Glaxo–Smith–Kline; Joseph M. Amaral, Johnson & Johnson; Mark Low, Global Cardiovascular Innovation Center, Dr. Aharon Schwartz and Prof. Avraham Karasik, Teva; Philip R. Schauer, MD, Cleveland Clinic, Tamar Howson, JSB; and Dr. Stephen L. Eck, Eli Lilly.

“This year’s conference will definitely provide an excellent opportunity to hear the great names of the field discussing the future of the industry,” said Ruti Alon, the chairperson of the organizing committee, who is also a senior partner of the Pitango venture capital fund and the chairperson of the Israeli Life Sciences Industry. “It has been a long time since we saw such an impressive group of experts, who personally shape the very near future of the health and medicine systems and willing to share their experience and knowledge with us all.”

The ILSI–Biomed Israel 2010 week is the annual leading event of the Israeli life–sciences industry. The event includes a professional international conference attended by experts from Israel and from around the world (CEOs and senior officers of bio–pharma and medical instrumentation companies, scientists and researchers, entrepreneurs, designers of public opinion acting in the field, venture capital fund managers and private investors) and a show of the latest innovations. Recognized internationally and considered to be the second in scope after the USA conference, the ILSI–Biomed Israel 2010 will be held in June between the 14th and the 16th at the David Intercontinental and Dan Panorama Hotels in Tel Aviv.

The event site: http://www.kenes.com/biomed/



CONTACT:

Donitza Marketing Communications
Mr. Nahum Donitza or Ms. Einat Aharonson, +972-3-5167336
www.donitza.co.il

KEYWORDS:   Middle East  Israel

INDUSTRY KEYWORDS:   Stem Cells  Health  Biotechnology  Cardiology  Oncology  Pharmaceutical  Research  Science  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.